ID   NQO1_RAT                Reviewed;         274 AA.
AC   P05982; Q63478;
DT   01-NOV-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   07-APR-2021, entry version 174.
DE   RecName: Full=NAD(P)H dehydrogenase [quinone] 1;
DE            EC=1.6.5.2 {ECO:0000269|PubMed:1703398, ECO:0000269|PubMed:7862630};
DE   AltName: Full=Azoreductase;
DE   AltName: Full=DT-diaphorase;
DE            Short=DTD;
DE   AltName: Full=Menadione reductase;
DE   AltName: Full=NAD(P)H:quinone oxidoreductase 1;
DE   AltName: Full=Phylloquinone reductase;
DE   AltName: Full=Quinone reductase 1;
DE            Short=QR1;
GN   Name=Nqo1; Synonyms=Nmor1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=3536915;
RA   Robertson J.A., Chen H.-C., Nebert D.W.;
RT   "NAD(P)H:menadione oxidoreductase. Novel purification of enzyme cDNA and
RT   complete amino acid sequence, and gene regulation.";
RL   J. Biol. Chem. 261:15794-15799(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE.
RA   Robertson J.A., Nebert D.W., Hankinson O.;
RT   "Autoregulation plus positive and negative elements controlling
RT   transcription of genes in the [Ah] battery.";
RL   Chem. Scr. 27:83-87(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Liver;
RX   PubMed=3100515;
RA   Bayney R.M., Rodkey J.A., Bennett C.D., Lu A.Y.H., Pickett C.B.;
RT   "Rat liver NAD(P)H: quinone reductase nucleotide sequence analysis of a
RT   quinone reductase cDNA clone and prediction of the amino acid sequence of
RT   the corresponding protein.";
RL   J. Biol. Chem. 262:572-575(1987).
RN   [4]
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Liver;
RX   PubMed=2480957;
RA   Bayney R.M., Morton M.R., Favreau L.V., Pickett C.B.;
RT   "Rat liver NAD(P)H:quinone reductase. Regulation of quinone reductase gene
RT   expression by planar aromatic compounds and determination of the exon
RT   structure of the quinone reductase structural gene.";
RL   J. Biol. Chem. 264:21793-21797(1989).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-274, CLEAVAGE OF INITIATOR METHIONINE, AND
RP   ACETYLATION AT ALA-2.
RX   PubMed=3143406; DOI=10.1021/bi00418a033;
RA   Haniu M., Yuan H., Chen S.A., Iyanagi T., Lee T.D., Shively J.E.;
RT   "Structure-function relationship of NAD(P)H:quinone reductase:
RT   characterization of NH2-terminal blocking group and essential tyrosine and
RT   lysine residues.";
RL   Biochemistry 27:6877-6883(1988).
RN   [7]
RP   NUCLEOTIDE SEQUENCE OF 1-57.
RX   PubMed=2963593; DOI=10.1016/0003-9861(88)90516-4;
RA   Bayney R.M., Pickett C.B.;
RT   "Rat liver NAD(P)H:quinone reductase: isolation of a quinone reductase
RT   structural gene and prediction of the NH2 terminal sequence of the protein
RT   by double-stranded sequencing of exons 1 and 2.";
RL   Arch. Biochem. Biophys. 260:847-850(1988).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-21, FUNCTION, COFACTOR, SUBCELLULAR LOCATION, AND
RP   CATALYTIC ACTIVITY.
RX   PubMed=1703398; DOI=10.1016/0003-9861(90)90648-i;
RA   Ma Q., Wang R., Yang C.S., Lu A.Y.H.;
RT   "Expression of mammalian DT-diaphorase in Escherichia coli: purification
RT   and characterization of the expressed protein.";
RL   Arch. Biochem. Biophys. 283:311-317(1990).
RN   [9]
RP   PROTEIN SEQUENCE OF 24-131 AND 156-270.
RX   PubMed=3144286; DOI=10.1016/0006-2952(88)90336-x;
RA   Knox R.J., Boland M.P., Friedlos F., Coles B., Southan C., Roberts J.J.;
RT   "The nitroreductase enzyme in Walker cells that activates 5-(aziridin-1-
RT   yl)-2,4-dinitrobenzamide (CB 1954) to 5-(aziridin-1-yl)-4-hydroxylamino-2-
RT   nitrobenzamide is a form of NAD(P)H dehydrogenase (quinone) (EC
RT   1.6.99.2).";
RL   Biochem. Pharmacol. 37:4671-4677(1988).
RN   [10]
RP   NUCLEOTIDE SEQUENCE OF 80-274.
RX   PubMed=2504488;
RA   Dear T.N., McDonald D.A., Kefford R.F.;
RT   "Transcriptional down-regulation of a rat gene, WDNM2, in metastatic DMBA-8
RT   cells.";
RL   Cancer Res. 49:5323-5328(1989).
RN   [11]
RP   PROTEIN SEQUENCE OF 147-156 AND 263-271.
RX   PubMed=2499768;
RA   Liu X.F., Yuan H., Haniu M., Iyanagi T., Shively J.E., Chen S.A.;
RT   "Reaction of rat liver DT-diaphorase (NAD(P)H:quinone acceptor reductase)
RT   with 5'-[p-(fluorosulfonyl)benzoyl]-adenosine.";
RL   Mol. Pharmacol. 35:818-822(1989).
RN   [12]
RP   MUTAGENESIS.
RX   PubMed=2141979; DOI=10.1016/0006-291x(90)92006-l;
RA   Forrest G.L., Qian J., Ma J.-X., Kaplan W.D., Akman S., Doroshow J.,
RA   Chen S.A.;
RT   "Rat liver NAD(P)H:quinone oxidoreductase: cDNA expression and site-
RT   directed mutagenesis.";
RL   Biochem. Biophys. Res. Commun. 169:1087-1093(1990).
RN   [13]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   MUTAGENESIS OF HIS-195.
RX   PubMed=7862630; DOI=10.1073/pnas.92.4.1043;
RA   Cui K., Lu A.Y., Yang C.S.;
RT   "Subunit functional studies of NAD(P)H:quinone oxidoreductase with a
RT   heterodimer approach.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:1043-1047(1995).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) IN COMPLEX WITH FAD AND DUROQUINONE,
RP   AND SUBUNIT.
RC   TISSUE=Liver;
RX   PubMed=7568029; DOI=10.1073/pnas.92.19.8846;
RA   Li R., Bianchet M.A., Talalay P., Amzel L.M.;
RT   "The three-dimensional structure of NAD(P)H:quinone reductase, a
RT   flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism
RT   of the two-electron reduction.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:8846-8850(1995).
RN   [15]
RP   ERRATUM OF PUBMED:7568029.
RA   Li R., Bianchet M.A., Talalay P., Amzel L.M.;
RL   Proc. Natl. Acad. Sci. U.S.A. 92:10815-10815(1995).
CC   -!- FUNCTION: The enzyme apparently serves as a quinone reductase in
CC       connection with conjugation reactions of hydroquinons involved in
CC       detoxification pathways as well as in biosynthetic processes such as
CC       the vitamin K-dependent gamma-carboxylation of glutamate residues in
CC       prothrombin synthesis. {ECO:0000269|PubMed:1703398,
CC       ECO:0000269|PubMed:7862630}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + H(+) + NADH = a quinol + NAD(+);
CC         Xref=Rhea:RHEA:46160, ChEBI:CHEBI:15378, ChEBI:CHEBI:24646,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:132124; EC=1.6.5.2;
CC         Evidence={ECO:0000269|PubMed:1703398, ECO:0000269|PubMed:7862630};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + H(+) + NADPH = a quinol + NADP(+);
CC         Xref=Rhea:RHEA:46164, ChEBI:CHEBI:15378, ChEBI:CHEBI:24646,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:132124; EC=1.6.5.2;
CC         Evidence={ECO:0000269|PubMed:1703398, ECO:0000269|PubMed:7862630};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:1703398};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=85 uM for NADH {ECO:0000269|PubMed:7862630};
CC         KM=39 uM for NADPH {ECO:0000269|PubMed:7862630};
CC         Note=kcat is 0.075 min(-1) NADH with as substrate. kcat is 0.074
CC         min(-1) with NADPH as substrate. {ECO:0000269|PubMed:7862630};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:7568029}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:1703398}.
CC   -!- INDUCTION: By polycyclic hydrocarbons (Governed by the aromatic
CC       hydrocarbon-responsive (AH) locus).
CC   -!- MISCELLANEOUS: Quinone reductase accepts electrons from both NADH and
CC       NADPH with equal efficiency.
CC   -!- MISCELLANEOUS: This protein is inhibited by dicoumarol.
CC   -!- SIMILARITY: Belongs to the NAD(P)H dehydrogenase (quinone) family.
CC       {ECO:0000305}.
CC   -!- CAUTION: PubMed:2480957 sequence seems incorrectly to be attributed to
CC       a mouse sequence while it really seems to correspond to the rat
CC       sequence. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA41988.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J02608; AAA41716.1; -; mRNA.
DR   EMBL; J02679; AAA41715.1; -; mRNA.
DR   EMBL; M36660; AAA39829.1; -; mRNA.
DR   EMBL; J02640; AAA41988.1; ALT_INIT; mRNA.
DR   EMBL; M31805; AAA41989.1; -; Genomic_DNA.
DR   EMBL; M31801; AAA41989.1; JOINED; Genomic_DNA.
DR   EMBL; M31802; AAA41989.1; JOINED; Genomic_DNA.
DR   EMBL; M31804; AAA41989.1; JOINED; Genomic_DNA.
DR   EMBL; M33039; AAA41990.1; -; Genomic_DNA.
DR   EMBL; M33038; AAA41990.1; JOINED; Genomic_DNA.
DR   EMBL; BC083542; AAH83542.1; -; mRNA.
DR   EMBL; X17464; -; NOT_ANNOTATED_CDS; mRNA.
DR   PIR; A34162; A34162.
DR   RefSeq; NP_058696.2; NM_017000.3.
DR   PDB; 1QRD; X-ray; 2.40 A; A/B=2-274.
DR   PDBsum; 1QRD; -.
DR   SMR; P05982; -.
DR   IntAct; P05982; 2.
DR   STRING; 10116.ENSRNOP00000017175; -.
DR   BindingDB; P05982; -.
DR   ChEMBL; CHEMBL3091269; -.
DR   iPTMnet; P05982; -.
DR   PhosphoSitePlus; P05982; -.
DR   World-2DPAGE; 0004:P05982; -.
DR   jPOST; P05982; -.
DR   PaxDb; P05982; -.
DR   PRIDE; P05982; -.
DR   Ensembl; ENSRNOT00000017174; ENSRNOP00000017175; ENSRNOG00000012772.
DR   GeneID; 24314; -.
DR   KEGG; rno:24314; -.
DR   UCSC; RGD:2503; rat.
DR   CTD; 1728; -.
DR   RGD; 2503; Nqo1.
DR   eggNOG; ENOG502QQMI; Eukaryota.
DR   GeneTree; ENSGT00940000159150; -.
DR   HOGENOM; CLU_058643_2_0_1; -.
DR   InParanoid; P05982; -.
DR   OMA; WFERVLV; -.
DR   OrthoDB; 1394543at2759; -.
DR   PhylomeDB; P05982; -.
DR   TreeFam; TF300296; -.
DR   BRENDA; 1.6.5.2; 5301.
DR   Reactome; R-RNO-350562; Regulation of ornithine decarboxylase (ODC).
DR   EvolutionaryTrace; P05982; -.
DR   PRO; PR:P05982; -.
DR   Proteomes; UP000002494; Chromosome 19.
DR   Bgee; ENSRNOG00000012772; Expressed in stomach and 22 other tissues.
DR   Genevisible; P05982; RN.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0005829; C:cytosol; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0003955; F:NAD(P)H dehydrogenase (quinone) activity; IDA:RGD.
DR   GO; GO:0050136; F:NADH dehydrogenase (quinone) activity; IEA:RHEA.
DR   GO; GO:0008753; F:NADPH dehydrogenase (quinone) activity; IEA:RHEA.
DR   GO; GO:0004784; F:superoxide dismutase activity; IMP:RGD.
DR   GO; GO:0007568; P:aging; IEP:RGD.
DR   GO; GO:0045454; P:cell redox homeostasis; ISO:RGD.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IDA:RGD.
DR   GO; GO:0071248; P:cellular response to metal ion; IEP:RGD.
DR   GO; GO:0006116; P:NADH oxidation; IDA:RGD.
DR   GO; GO:0070995; P:NADPH oxidation; IDA:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:RGD.
DR   GO; GO:0043086; P:negative regulation of catalytic activity; ISO:RGD.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IMP:RGD.
DR   GO; GO:0043279; P:response to alkaloid; IEP:RGD.
DR   GO; GO:0014075; P:response to amine; IDA:RGD.
DR   GO; GO:0009743; P:response to carbohydrate; IEP:RGD.
DR   GO; GO:0042493; P:response to drug; IEP:RGD.
DR   GO; GO:0051602; P:response to electrical stimulus; IEP:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:1905395; P:response to flavonoid; IEP:RGD.
DR   GO; GO:0009725; P:response to hormone; IEP:RGD.
DR   GO; GO:1904880; P:response to hydrogen sulfide; IEP:RGD.
DR   GO; GO:0002931; P:response to ischemia; IEP:RGD.
DR   GO; GO:1904844; P:response to L-glutamine; IDA:RGD.
DR   GO; GO:1901698; P:response to nitrogen compound; IEP:RGD.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0010033; P:response to organic substance; IEP:RGD.
DR   GO; GO:0006979; P:response to oxidative stress; IEP:RGD.
DR   GO; GO:0033574; P:response to testosterone; IEP:RGD.
DR   GO; GO:1904772; P:response to tetrachloromethane; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IDA:RGD.
DR   GO; GO:0006801; P:superoxide metabolic process; IMP:RGD.
DR   Gene3D; 3.40.50.360; -; 1.
DR   InterPro; IPR003680; Flavodoxin_fold.
DR   InterPro; IPR029039; Flavoprotein-like_sf.
DR   Pfam; PF02525; Flavodoxin_2; 1.
DR   SUPFAM; SSF52218; SSF52218; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Direct protein sequencing; FAD;
KW   Flavoprotein; Isopeptide bond; NAD; NADP; Oxidoreductase; Phosphoprotein;
KW   Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:1703398,
FT                   ECO:0000269|PubMed:3143406"
FT   CHAIN           2..274
FT                   /note="NAD(P)H dehydrogenase [quinone] 1"
FT                   /id="PRO_0000071625"
FT   NP_BIND         18..19
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:7568029"
FT   NP_BIND         104..107
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:7568029"
FT   NP_BIND         148..151
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:7568029"
FT   REGION          126..128
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250"
FT   BINDING         12
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:7568029"
FT   BINDING         67
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:7568029"
FT   BINDING         156
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:7568029"
FT   BINDING         201
FT                   /note="FAD"
FT                   /evidence="ECO:0000269|PubMed:7568029"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|PubMed:3143406"
FT   MOD_RES         82
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P15559"
FT   CROSSLNK        251
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P15559"
FT   MUTAGEN         117..118
FT                   /note="FE->KK: Destroys enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:2141979"
FT   MUTAGEN         161
FT                   /note="V->D: Destroys enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:2141979"
FT   MUTAGEN         164
FT                   /note="D->Q: Destroys enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:2141979"
FT   MUTAGEN         195
FT                   /note="H->A: Induces a very low catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:7862630"
FT   CONFLICT        31
FT                   /note="Missing (in Ref. 9; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        80
FT                   /note="R -> G (in Ref. 10; X17464)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        135
FT                   /note="K -> Q (in Ref. 3; AAA41988)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        216
FT                   /note="W -> E (in Ref. 9; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        227
FT                   /note="S -> E (in Ref. 9; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        263
FT                   /note="S -> I (in Ref. 9; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        269
FT                   /note="Q -> E (in Ref. 11; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   STRAND          5..10
FT                   /evidence="ECO:0007744|PDB:1QRD"
FT   HELIX           18..32
FT                   /evidence="ECO:0007744|PDB:1QRD"
FT   STRAND          36..41
FT                   /evidence="ECO:0007744|PDB:1QRD"
FT   TURN            42..46
FT                   /evidence="ECO:0007744|PDB:1QRD"
FT   HELIX           53..55
FT                   /evidence="ECO:0007744|PDB:1QRD"
FT   HELIX           68..78
FT                   /evidence="ECO:0007744|PDB:1QRD"
FT   HELIX           83..94
FT                   /evidence="ECO:0007744|PDB:1QRD"
FT   STRAND          96..103
FT                   /evidence="ECO:0007744|PDB:1QRD"
FT   HELIX           111..120
FT                   /evidence="ECO:0007744|PDB:1QRD"
FT   TURN            123..125
FT                   /evidence="ECO:0007744|PDB:1QRD"
FT   HELIX           133..135
FT                   /evidence="ECO:0007744|PDB:1QRD"
FT   TURN            137..140
FT                   /evidence="ECO:0007744|PDB:1QRD"
FT   STRAND          142..148
FT                   /evidence="ECO:0007744|PDB:1QRD"
FT   HELIX           153..156
FT                   /evidence="ECO:0007744|PDB:1QRD"
FT   HELIX           165..173
FT                   /evidence="ECO:0007744|PDB:1QRD"
FT   HELIX           174..178
FT                   /evidence="ECO:0007744|PDB:1QRD"
FT   TURN            179..181
FT                   /evidence="ECO:0007744|PDB:1QRD"
FT   STRAND          188..190
FT                   /evidence="ECO:0007744|PDB:1QRD"
FT   HELIX           193..195
FT                   /evidence="ECO:0007744|PDB:1QRD"
FT   HELIX           198..212
FT                   /evidence="ECO:0007744|PDB:1QRD"
FT   HELIX           215..217
FT                   /evidence="ECO:0007744|PDB:1QRD"
FT   HELIX           226..228
FT                   /evidence="ECO:0007744|PDB:1QRD"
FT   TURN            233..236
FT                   /evidence="ECO:0007744|PDB:1QRD"
FT   HELIX           241..247
FT                   /evidence="ECO:0007744|PDB:1QRD"
FT   STRAND          254..256
FT                   /evidence="ECO:0007744|PDB:1QRD"
FT   TURN            266..270
FT                   /evidence="ECO:0007744|PDB:1QRD"
SQ   SEQUENCE   274 AA;  30947 MW;  40E8801320A20F09 CRC64;
     MAVRRALIVL AHAERTSFNY AMKEAAVEAL KKKGWEVVES DLYAMNFNPL ISRNDITGEP
     KDSENFQYPV ESSLAYKEGR LSPDIVAEQK KLEAADLVIF QFPLYWFGVP AILKGWFERV
     LVAGFAYTYA TMYDKGPFQN KKTLLSITTG GSGSMYSLQG VHGDMNVILW PIQSGILRFC
     GFQVLEPQLV YSIGHTPPDA RVQVLEGWKK RLETVWEESP LYFAPSSLFD LNFQAGFLLK
     KEVQEEQKKN KFGLSVGHHL GKSIPADNQI KARK
//
